Main menu
Edison Group
  • Home
  • Sparks
  • Equities

    Equities

    View All Equities

    Equities by Sector

    YXT.com

    MCap

    USD127m

    Last close

    USD23.43

    ▲ 20.23 (632.19%)

    Northern Data Group

    MCap

    EUR486m

    Last close

    EUR6.28

    ▲ −1.28 (−16.88%)

    Bodycote

    MCap

    GBP1,572m

    Last close

    GBP9.14

    ▲ −9.00 (−0.98%)

  • Sectors

    Sectors

  • Megatrends

    Megatrends

  • Thematics

    Thematics

    View All Thematics

    Latest

  • Audiovisual

    Audiovisual

    View All Audiovisual

    Latest

Executive interview – BiondVax Pharmaceuticals

Executive interview – BiondVax Pharmaceuticals

BiondVax Pharmaceuticals (Nasdaq: BVXV) is a clinical biopharmaceutical company developing a universal flu vaccine, known as M-001. M-001 is currently undergoing a pivotal, clinical efficacy, Phase III trial in about 12,400 participants, the results of which are expected by the end of 2020.

M-001 is designed to provide multi-season and multi-strain protection against all human influenza virus strains. In six completed clinical trials to date, the vaccine was shown to be safe, well tolerated and immunogenic to a broad range of flu strains.

< Previous
Next >

You may also be interested in these:

Metals & Mining

The Metals Company – equity proposition

Investment Companies

Vantage: Rockwood Strategic – UK small-cap value and active engagement
Cookie Policy Overview
Edison Group

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping us understand which section of the website you find more interesting and useful. See our Cookie Policy for more information.

Strictly necessary and functional

These cookies are used to deliver our website and content. Strictly necessary cookies relate to our hosting environment, and functional cookies are used to facilitate social logins, social sharing and rich-media content embeds.

Advertising

Advertising Cookies collect information about your browsing habits such as the pages you visit and links you follow. These audience insights are used to make our website more relevant.

Performance

Performance Cookies collect anonymous information designed to help us improve the site and respond to the needs of our audiences. We use this information to make our site faster, more relevant and improve the navigation for all users.